Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


US, German scientists win Nobel medicine prize for work on light and brain
Nigeria military aircraft crashes with 32 aboard
At least 22 dead after boats collide on Congo river
Spanish PM Sanchez calls snap election for November 29
Hundreds of French schools stay closed ahead of nationwide day of student protests